Side-by-side comparison of AI visibility scores, market position, and capabilities
Boston phygital NFC sneaker company (founded 2021) with $7.58M from Accomplice/Castle Island Ventures; MFA Boston/Kentucky Derby/Marvel partnerships using NFC+NFT chips competing with Nike Authentics for brand authentication phygital products.
Endstate is a Boston, Massachusetts-based phygital sneaker and apparel company — having raised $7.58 million from investors including Accomplice VC, Archetype Fund, and Castle Island Ventures — creating limited-edition physical sneakers embedded with NFC (Near Field Communication) chips that connect to digital NFT twins, enabling brand authentication, exclusive content access, and ongoing consumer engagement through a tap of a smartphone. Founded in 2021 by CEO Bennett Collen (blockchain professor at Boston College) and veteran footwear designer Stephanie Howard (25+ years designing for Reebok, New Balance, and Timberland), Endstate has established cultural partnerships with the Museum of Fine Arts Boston (multiple exhibition collaborations including the Van Gogh: The Roulin Family Portraits exhibition), the Kentucky Derby (150th Anniversary commemorative sneaker), Marvel Entertainment, and streetwear retailer BAIT Inc. Each Endstate sneaker incorporates a proprietary NFC chip embedded in the tongue; customers tap the chip with any smartphone to access exclusive content, authentication records, and special experiences without requiring a dedicated app.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.